Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pyoderma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07444684
What this trial is testing

Evaluate SHR-1139 Injection in Patients With Pyoderma Gangrenosum

Who this might be right for
Pyoderma Gangrenosum
Guangdong Hengrui Pharmaceutical Co., Ltd 20
Testing effectiveness (Phase 2)Ended earlyNCT06092216
What this trial is testing

Spesolimab in Pyoderma Gangrenosum

Who this might be right for
Pyoderma Gangrenosum
Icahn School of Medicine at Mount Sinai 5
Large-scale testing (Phase 3)Ended earlyNCT02326740
What this trial is testing

An Efficacy and Safety Study of Gevokizumab in Treating Active Ulcers of Pyoderma Gangrenosum

Who this might be right for
Pyoderma Gangrenosum
XOMA (US) LLC 9
Post-approval studies (Phase 4)WithdrawnNCT00202891
What this trial is testing

Sisomicin Cream Vs Nadifloxacin Cream in Primary Pyodermas (Study P04460)

Who this might be right for
Pyoderma
Merck Sharp & Dohme LLC
Large-scale testing (Phase 3)Ended earlyNCT02315417
What this trial is testing

An Efficacy and Safety Study of Gevokizumab in Treating Active Ulcers of Pyoderma Gangrenosum

Who this might be right for
Pyoderma Gangrenosum
XOMA (US) LLC 16
Very early researchWithdrawnNCT05821374
What this trial is testing

Deucravacitinib in PG

Who this might be right for
Pyoderma Gangrenosum
Dartmouth-Hitchcock Medical Center
Large-scale testing (Phase 3)Study completedNCT03311464
What this trial is testing

A Study Assessing the Efficacy and Safety of Adalimumab in Active Ulcer(s) of Pyoderma Gangrenosum in Participants in Japan

Who this might be right for
Pyoderma Gangrenosum
AbbVie 22
Testing effectiveness (Phase 2)UnknownNCT05890703
What this trial is testing

Painless Sharp Wound Debridement With Lidocaine-23%-Tetra-caine-7% Gel Versus EMLA 5% Cream

Who this might be right for
Ulcus CrurisEcthymaUlcer, Leg+1 more
Juerg Hafner 40
Testing effectiveness (Phase 2)Study completedNCT01882504
What this trial is testing

Proof of Concept Study of Gevokizumab in the Treatment of Pyoderma Gangrenosum

Who this might be right for
Pyoderma Gangrenosum
XOMA (US) LLC 8
Testing effectiveness (Phase 2)Study completedNCT01233570
What this trial is testing

Topical Tacrolimus 0.1% Ointment For Treatment Of Cutaneous Crohn's Disease

Who this might be right for
Crohn Disease
University of Aberdeen 20
Testing effectiveness (Phase 2)WithdrawnNCT00690846
What this trial is testing

Study to Determine the Safety and Efficacy of Adalimumab in the Treatment of Pyoderma Gangrenosum

Who this might be right for
Pyoderma Gangrenosum
Wake Forest University Health Sciences
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07783412
What this trial is testing

Topical Ruxolitinib in the Treatment of Adults With Pyoderma Gangrenosum

Who this might be right for
Pyoderma Gangrenosum
Oregon Health and Science University 12
Not applicableUnknownNCT01952275
What this trial is testing

Observational Study of the Genetic Architecture of Neutrophil-Mediated Inflammatory Skin Diseases

Who this might be right for
Other Specified Inflammatory Disorders of Skin or Subcutaneous TissuePyoderma GangrenosumErosive Pustular Dermatosis of the Scalp+25 more
University of Zurich 600
Very early researchStudy completedNCT04895566
What this trial is testing

Phase 0/1 Local Application of the Monoclonal Antibody (Mab) sB24M in Patients With Purulent Pyoderma

Who this might be right for
PyodermaPyoderma GangrenosumPyoderma Vegetans+1 more
SWISS BIOPHARMA MED GmbH 10
Early research (Phase 1)Study completedNCT03386942
What this trial is testing

MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin) in Participants With Solid Tumors

Who this might be right for
Solid Tumors
Eisai Inc. 82
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07767864
What this trial is testing

Efficacy of Bimekizumab in Adults With Pyoderma Gangrenosum

Who this might be right for
Pyoderma Gangrenosum
Oregon Health and Science University 15
Not applicableLooking for participantsNCT02280733
What this trial is testing

A Real-World Registry of Chronic Wounds and Ulcers

Who this might be right for
Diabetic FootPressure UlcerSurgical Wound Dehiscence+17 more
U.S. Wound Registry 300,000
Not applicableStudy completedNCT00284882
What this trial is testing

Incidence of Group A Strep Pharyngitis in School Children in Fiji

Who this might be right for
Streptococcus Group A
National Institute of Allergy and Infectious Diseases (NIAID) 1,000
Testing effectiveness (Phase 2)Study completedNCT03971643
What this trial is testing

Exploratory Study of IFX-1 in Patients With Pyoderma Gangrenosum

Who this might be right for
Pyoderma Gangrenosum
InflaRx GmbH 19
Not applicableWithdrawnNCT05984654
What this trial is testing

Autologous Platelet-Rich Plasma Therapy in the Treatment of Pyoderma Gangrenosum

Who this might be right for
Pyoderma Gangrenosum
Ohio State University
Next Page